Latex sublingual immunotherapy: can its safety be predicted?

Annals of Allergy, Asthma and Immunology

Volumn 104, Issue 4, 2010, Pages 339-342

  Buyukozturk, Suna ^a   Gelincik, Asli ^a   Özşeker, Ferhan ^a   Çolakoǧlu, Bahattin ^a   Dal, Murat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; LATEX;

ADULT; ALLERGY; ANAPHYLAXIS; ARTICLE; BRONCHUS OBSTRUCTION; CHEST TIGHTNESS; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DYSPNEA; FEMALE; FLUSHING; HEALTH CARE PERSONNEL; HUMAN; HYPOTENSION; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SIDE EFFECT; SUBLINGUAL LATEX IMMUNOTHERAPY; WHEEZING;

ADMINISTRATION, SUBLINGUAL; ADULT; ALLERGENS; ANAPHYLAXIS; ANTIMICROBIAL CATIONIC PEPTIDES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; LATEX HYPERSENSITIVITY; MALE; PLANT LECTINS; PLANT PROTEINS; RISK; SKIN TESTS; TREATMENT OUTCOME;

EID: 77950021913     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.01.014     Document Type: Article

References (13)

1. Weissman D.N., and Lewis D.M. Allergic and latex-specific sensitization: route, frequency, and amount of exposure that are required to initiate IgE production. J Allergy Clin Immunol 110 (2002) S57-S63
2. Cullinan P., Brown R., Field A., et al. Latex allergy: a position paper of the British Society of Allergy and Clinical Immunology. Clin Exp Allergy 33 (2003) 1484-1499
3. Heilman D.K., Jones R.T., Swanson M.C., and Yunginger J.W. A prospective, controlled study showing that rubber gloves are the major contributor to latex aeroallergen levels in the operating room. J Allergy Clin Immunol 98 (1996) 535-544
4. Tabar A.I., Anda M., Bonifazi F., et al. Specific immunotherapy with standardized latex extract versus placebo in latex-allergic patients. Int Arch Allergy Immunol 141 (2006) 369-376
5. Kurup V.P., and Fink J.N. The spectrum of immunologic sensitization in latex allergy. Allergy 56 (2001) 2-12
6. Ownby D.R. Manifestations of latex allergy. In: Fink J.N. (Ed). Latex Allergy: Immunology and Allergy Clinics of North America (1995), WB Saunders, Philadelphia, PA 31-43
7. Sastre J., Fernandez-Nieto M., Rico P., et al. Specific immunotherapy with a standardized latex extract in allergic workers: a double-blind, placebo-controlled study. J Allergy Clin Immunol 111 (2003) 985-994
8. Leynadier F., Herman D., Vervloet D., and Andre C. Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workers. J Allergy Clin Immunol 106 (2000) 585-590
9. Nettis E., Colanardi M.C., Soccio A.L., et al. Double-blind placebo controlled study of sublingual immunotherapy in patients with latex induced urticaria: a 12-month study. Br J Dermatol 156 (2007) 674-681
10. Nucera E., Schiavino D., Sabato V., et al. Sublingual immunotherapy for latex allergy: tolerability and safety profile of rush build-up phase. Curr Med Res Opin 24 (2008) 1147-1154
11. Yagami A., Suzuki K., Saito H., and Matsunaga K. Hevb 6.02 is the most important allergen in health care workers sensitized occupationally by natural rubber latex gloves. Allergol Int 58 (2009) 347-355
12. Sastre J., Raulf-Heimsoth M., Rihs H.P., et al. IgE reactivity to latex allergens among sensitized healthcare workers before and after immunotherapy with latex. Allergy 61 (2006) 206-210
13. Rolland J.M., and O'Hehir R.E. Latex allergy: a model for therapy. Clin Exp Allergy 38 (2008) 898-912